NDC 81033-102-05 - Guaifenesin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-102
- Requested NDC
- 81033-102-05
- Package NDCs from labels
- 81033-102-16, 81033-102-05, 81033-102-51, 81033-102-10, 81033-102-52
- Manufacturer
- KESIN PHARMA CORPORATION | Kesin Pharma
- Effective date
- 2025-04-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Guaifenesin - KESIN PHARMA CORPORATION | Kesin Pharma | KESIN PHARMA CORPORATION | Kesin Pharma | 2025-04-01 | HUMAN OTC DRUG LABEL |
| Guaifenesin - KESIN PHARMA CORPORATION | Kesin Pharma | Belleview Biosciences | KESIN PHARMA CORPORATION | Kesin Pharma | Belleview Biosciences | 2025-03-28 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-102-05 | Guaifenesin | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 7 | |
| 81033-102-10 | Guaifenesin | 10 mL in 1 CUP, UNIT-DOSE | LIQUID | 10 | 7 | |
| 81033-102-51 | Guaifenesin | 50 in 1 CARTON | LIQUID | 50 | 7 | |
| 81033-102-52 | Guaifenesin | 50 in 1 CARTON | LIQUID | 50 | 7 | |
| 81033-102-16 | Guaifenesin | 473 mL in 1 BOTTLE | LIQUID | 473 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 81033-102 | GUAIFENESIN LIQUID [KESIN PHARMA CORPORATION] | 7 | Current NDC, 4 package rows | 20250331_365c01b7-a197-4876-85fc-42204f787e3a.zip |
| 81033-102 | GUAIFENESIN LIQUID [KESIN PHARMA CORPORATION] | 1 | Current NDC, 1 package rows | 20250406_31b8ad0a-3637-03db-e063-6394a90acdc3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-102-05 | ML - Milliliter | 81033-102 | c04493a2-a5df-4be5-86e1-38cd698bbd63 | 1 | 2024-03-12 |
| 81033-102-10 | ML - Milliliter | 81033-102 | a990cc84-2678-4699-8dca-ec8808a024a4 | 1 | 2024-04-05 |
| 81033-102-16 | ML - Milliliter | 81033-102 | 7a1f8916-cb71-4e4c-a447-b4f532f27ea3 | 1 | 2025-06-13 |
| 81033-102-51 | ML - Milliliter | 81033-102 | 118824ef-231f-4404-85a9-9e31242703de | 1 | 2024-01-04 |
| 81033-102-52 | ML - Milliliter | 81033-102 | 0be6c67c-993a-4d6d-9ecc-515e876c5d39 | 1 | 2024-01-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | efb69cc1-a745-6efc-e053-2a95a90abdc9 | 2026-09-08 | Warnings | M012 495W7451VQ |
| Vicks NyQuil VapoCOOL Severe COLD and FLU plus CONGESTION | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DOXYLAMINE SUCCINATE, AND DEXTROMETHORPHAN HYDROBROMIDE | The Procter & Gamble Manufacturing Company | efb5f0b9-9825-ab23-e053-2995a90a26ab | 2026-09-08 | Warnings | M012 |
| Vicks DayQuil and Nyquil VapoCOOL Severe COLD and FLU plus CONGESTION | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | f4328b44-cdfa-41aa-e053-2995a90a2728 | 2026-09-08 | Warnings | M012 |
| Vicks childrens Cough Congestion | PHENYLEPHRINE HCL, DEXTROMETHORPHAN HBR, GUAIFENESIN | The Procter & Gamble Manufacturing Company | e2356457-9791-3710-e053-2995a90ad140 | 2026-09-08 | Warnings | M012 495W7451VQ |
| Cold Multi-Symptom | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Wal-Mart Stores Inc | 077fac1a-0ec5-40d9-8861-a281b48f650a | 2026-09-08 | Warnings | M012 |
| Overnight Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, TRIPROLIDINE HCL | RARITAN PHARMACEUTICALS | eef00453-9f4f-4a05-bb4e-49b94705b52c | 2026-09-08 | Warnings | M012 |
| Nighttime Severe Cold and Cough | ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE | RARITAN PHARMACEUTICALS INC | 9819155b-2713-42be-867e-16605e7643d0 | 2026-09-08 | Warnings | M012 |
| Cold and Flu HBP | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE | WALMART INC. | f9d1dfd1-527f-491d-9188-14886ac70ced | 2026-09-08 | Warnings | M012 |
| severe cold and cough daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | RARITAN PHARMACEUTICALS INC | 3ce8508e-7d9d-4413-858a-8f952e760c01 | 2026-09-08 | Warnings | M012 |
| Multi Symptom Severe Cold | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | RARITAN PHARMACEUTICALS INC | d9606c9a-31b1-4121-9870-809a05f5b68a | 2026-09-08 | Warnings | M012 |
| Mucus Relief DM Honey and Berry Flavor | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | RARITAN PHARMACEUTICALS INC | 4898b1c2-55ef-4589-982b-2279c01707e5 | 2026-09-08 | Warnings | M012 495W7451VQ |
| Mucus Relief Severe Congestion and Cough | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Chain Drug Marketing Association, Inc. | 2a7afe03-3c34-4e30-827e-b3bb2568cb97 | 2026-09-08 | Warnings | M012 495W7451VQ |
| Drx Choice childrens allergy chews | DIPHENHYDRAMINE HCL | RARITAN PHARMACEUTICALS INC | dd2be906-bd0a-437c-9693-54b9391a5da3 | 2026-09-05 | Warnings | M012 |
| Severe Congestion and Pain | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Meijer Distribution, Inc. | 49235f4f-e661-4a83-88ef-b9a956848777 | 2026-09-04 | Warnings | M012 495W7451VQ |
| nasal | OXYMETAZOLINE HYDROCHLORIDE | Rite Aid Corporation | 71845bf9-8981-4ca0-a62c-dbef102b1b02 | 2026-09-04 | Warnings | M012 |
| NIGHTTIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Amazon.com Services LLC | 774d2bde-9f57-4ced-800a-cada39c685ed | 2026-09-04 | Warnings | M012 |
| Nostrilla | OXYMETAZOLINE HYDROCHLORIDE | Insight Pharmaceuticals LLC | 86217847-8e2b-48cc-b289-4987fd3aa7c3 | 2026-09-04 | Warnings | M012 |
| tussin cough chest congestion | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Rite Aid Corporation | 86fc3723-5fc5-4de5-bd04-7774c2abe539 | 2026-09-04 | Warnings | M012 495W7451VQ |
| Cough and Cold HBP | CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR | Topco Associates, LLC | ed576bf1-3949-423e-af2e-e4b1a3839b21 | 2026-09-04 | Warnings | M012 |
| tussin nighttime cough | DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Rite Aid Corporation | 80d51af8-3a7b-4d22-8d4f-df5f91913047 | 2026-09-04 | Warnings | M012 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.